Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints
- PMID: 15742638
Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints
Abstract
Major constraints to the adoption of a 'vaccination to live' policy during an outbreak of foot-and-mouth disease (FMD) in a previously FMD-free country are the dual problems in the development of persistent infection (>28 days) in some vaccinated ruminants exposed to virulent virus and reliably detecting these persistently infected animals. Rapid advances in immunology, virology, molecular biology and information management present significant opportunities for improving the management of FMD outbreaks using a variety of scientifically advanced tools without the need for slaughtering large numbers of animals. A more rapid return to FMD-free status should be capable of being achieved without massive slaughter of animals through: (i) improvements in vaccine efficacy, onset of immunity, and marker specificity; (ii) development of anti-viral compounds as an aid in the control of outbreaks with or without vaccination; (iii) improvement of rapid diagnostic tests to detect early infection and persistent infection accurately and (iv) the capture, validation and management of data on animal identification, vaccination and infection status, and movement. The most effective improvements will occur if all these strategies are used in combination.
Similar articles
-
Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.Biologicals. 2005 Dec;33(4):227-34. doi: 10.1016/j.biologicals.2005.08.009. Epub 2005 Nov 14. Biologicals. 2005. PMID: 16289996
-
The use of vaccines in South American foot-and-mouth disease eradication programmes.Dev Biol (Basel). 2004;119:33-40. Dev Biol (Basel). 2004. PMID: 15742616 Review.
-
Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.Vaccine. 2005 Dec 30;23(50):5775-82. doi: 10.1016/j.vaccine.2005.07.043. Epub 2005 Aug 8. Vaccine. 2005. PMID: 16153756
-
Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle.Vaccine. 2006 Oct 30;24(42-43):6503-12. doi: 10.1016/j.vaccine.2006.06.032. Epub 2006 Jul 5. Vaccine. 2006. PMID: 16872727 Review.
-
Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America.Expert Rev Vaccines. 2005 Dec;4(6):903-13. doi: 10.1586/14760584.4.6.903. Expert Rev Vaccines. 2005. PMID: 16372885 Review.
Cited by
-
Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus.Virus Genes. 2007 Oct;35(2):347-57. doi: 10.1007/s11262-007-0105-0. Epub 2007 May 12. Virus Genes. 2007. PMID: 17497212
-
Modeling target-density-based cull strategies to contain foot-and-mouth disease outbreaks.PeerJ. 2024 Feb 29;12:e16998. doi: 10.7717/peerj.16998. eCollection 2024. PeerJ. 2024. PMID: 38436010 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical